Answers are grounded in this paper and cite their sources.
BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) exhibits a marked female predominance. Despite this "estrogen paradox," the molecular basis of sex-associated pathogenesis remains incompletely understood, limiting the development of precision diagnostic strategies. OBJECTIVE: To develop a sex-stratified computational framework that integrates transcriptomic profiling and ensemble machine learning to identify female-associated candidate biomarkers in IPAH. METHODS: Sex-stratified differentially expressed genes (DEGs) were derived from pulmonary arterial endothelial cells (GSE303084, n = 48) and lung tissue (GSE126262, n = 16). Functional mechanisms were explored via GO/KEGG enrichment and protein-protein interaction (PPI) networks. A consensus machine learning framework incorporating 12 feature selection algorithms prioritized stable candidate biomarkers. Model performance was evaluated using a leakage-free repeated stratified 5-fold cross-validation framework, followed by independent external validation in a female IPAH cohort. Sex-associated immune landscapes were characterized via CIBERSORTx-based deconvolution. RESULTS: Female-associated DEGs were associated with metabolic dysregulation, lysosomal pathways, and TGF-β/Wnt signaling. PPI analysis identified MMP1, SFRP1, SNAI2, ADAM12, and INHBA as central hub genes. The ensemble framework prioritized METTL27 and CDH11 as candidate biomarkers. A two-gene signature (METTL27 + CDH11) demonstrated robust performance under leakage-free repeated cross-validation (XGBoost mean AUC 0.875 ± 0.161) and correctly identified 26 of 28 female IPAH patients in an independent external cohort (patient-detection sensitivity 92.9%; 95% CI, 77.4-98.0%). Immune deconvolution revealed marked sex dimorphism, with adaptive immune enrichment in females and innate myeloid predominance in males. CONCLUSION: Our approach identifies a candidate two-gene signature (METTL27/CDH11) for female IPAH and highlights TGF-β/Wnt signaling, metabolic, and immune dimorphism as key drivers of sex-associated pathogenesis. These findings provide a foundation for future clinical and experimental validation of sex-informed candidate molecular biomarkers in IPAH.
No takes yet. Share an insight, caveat, or question.
Pourdadashi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: